AstraZeneca is a pharmaceutical and biotechnology company focusing on oncology, cardiovascular, gastrointestinal, infection, neuroscience, respiratory and inflammation products. It is also known for  developing the Oxford–AstraZeneca Covid-19 vaccine. The company makes occasional investments in US, European and Asia-based drug developers from series A stage onwards, and had previously invested out of a $400m venture firm called MedImmune Ventures for over a decade from 2002.

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.



Not sure if you have a subscription?